Discovery of Potential Antiviral Compounds against Hendra Virus by Targeting Its Receptor-Binding Protein (G) Using Computational Approaches
Hendra virus (HeV) belongs to the paramyxoviridae family of viruses which is associated with the respiratory distress, neurological illness, and potential fatality of the affected individuals. So far, no competitive approved therapeutic substance is available for HeV. For that reason, the current re...
Main Authors: | Faisal Ahmad, Aqel Albutti, Muhammad Hamza Tariq, Ghufranud Din, Muhammad Tahir ul Qamar, Sajjad Ahmad |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-01-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/27/2/554 |
Similar Items
-
Sero-Monitoring of Horses Demonstrates the Equivac<sup>®</sup> HeV Hendra Virus Vaccine to Be Highly Effective in Inducing Neutralising Antibody Titres
by: Kim Halpin, et al.
Published: (2021-07-01) -
Serological Hendra Virus Diagnostics Using an Indirect ELISA-Based DIVA Approach with Recombinant Hendra G and N Proteins
by: Anne Balkema-Buschmann, et al.
Published: (2022-05-01) -
Communication Interventions and Assessment of Drivers for Hendra Virus Vaccination Uptake
by: Jessica N. Kropich-Grant, et al.
Published: (2023-05-01) -
Analysis of Hendra Virus Fusion Protein N-Terminal Transmembrane Residues
by: Chelsea T. Barrett, et al.
Published: (2021-11-01) -
Aggregated Hendra virus C-protein activates the NLRP3 inflammasome to induce inflammation
by: Kristian Barry, et al.
Published: (2023-11-01)